Speaker Series: Foundation Funded Research Grants
This speaker series will highlight the mission and impact behind our Foundation-funded grants program, exploring…
Benson Clinical Research Fellowship
Claire Bergstrom Johnson My decision to apply for the Benson Fellowship stems from my commitment…
Leadership Collaborative
The first biennial GBS|CIDP Foundation Leadership Collaborative convened in Boston! Every two years, the Foundation will bring…
How You Can Manage Fatigue
Submitted by Dr. Gareth Parry, Global Medical Advisory Board Member and GBS Support Group NZ…
Research Article: Pathogenesis of GBS based on mice strains
Development of a major histocompatibility complex class II conditional knockout mouse to study cell-specific and…
2024 MMN Research Grant Announcement
In 2022, the Foundation embarked on fundraising endeavors aimed at research dedicated to advancing treatments…
Inspiring the Next Generation of Research at the GBS|CIDP Foundation International Patient Symposium
As part of the 2023 International Patient Symposium, the Foundation was thrilled to welcome seven…
A one-year Research Update from the 2022 Benson Fellowship Awardee
A one-year Research Update from the 2022 Benson Fellowship Awardee, Elba Pascual-Goñi MD, PhD. …
Children with rapid-onset paralysis: is it GBS?
Children with rapid-onset paralysis: is it GBS? by Patricia Blomkwist An interesting article* was published…
Announcing 2022 Benson Fellowship Awardee
Announcing 2022 Benson Fellowship Awardee, Elba Pascual Goñi MD, PhD The Benson Fellowship is a…
An Update from the International Guillain-Barre Study (IGOS) by Dr. Bart Jacobs
The IGOS-1000 cohort has now been tested for the main preceding infections and is currently…
New Study Reveals No Association Between COVID-19 and Guillain-Barré Syndrome
The GBS|CIDP Foundation is committed to sharing the most accurate information from the world’s leading…
2018 GBS|CIDP Foundation Research Grant Recipient Publishes Update in Journal of Neurology, Neurosurgery & Psychology
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and…
Foundation Hosted Patient Listening Session on Guillain-Barre Syndrome with The FDA
On September 29, 2020, the GBS|CIDP Foundation International organized a patient-led listening session on Guillain-Barre…
Your Donations in Action
Findings of 2016 GBS|CIDP Research Grant Support Article Published by EAN In 2016 The GBS|CIDP…
INCbase
INCbase Update Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder that affects different people…
2020 GBS|CIDP Foundation International Research Grants Announced!
Research grants are made possible through the benevolence of many sources, including the Helen S.…
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Update from the International Guillain–Barré Syndrome Outcome Study (IGOS)
Diagnosis and management of Guillain–Barré syndrome in ten steps Portuguese Spanish Chinese Nature Reviews Neurology: https://www.nature.com/articles/s41582-019-0250-9; Published Sept 20,…
New Research Grant Announced: Exploring possible role of TGR5 and FXR in autoimmune neuropathy
Please join us in congratulating, 2019 GBS|CIDP Research Grant Recipient, Betty Soliven, MD for her…
Announcing 2019 GBS|CIDP Research Grant Awardee, Ruth Huizinga, PhD, Assistant Professor, Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Please join us in congratulating, 2019 GBS|CIDP Research Grant Recipient, Ruth Huizinga, PhD, Assistant professor,…
Please join us in Congratulating 2019 GBS|CIDP Foundation Research Grant Recipient, Dr. Eduardo Nobile-Orazio
Study Description: A randomized controlled trial with Rituximab versus placebo in patients with chronic inflammatory…
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
Published in The Lancet, May 7, 2019Co-authored by Carina Bunschoten, Bart C Jacobs, Peter U…
Dr. Bart Jacobs, Vice Chairman of GMAB, and co-authors, “Editor’s Choice,” Brain Journal
Regional variation of Guillain-Barré syndrome Brain, Volume 141, Issue 10, 1 October 2018, Pages 2866–2877…
CIDP Disease Burden — Results of a US Nationwide Patient Survey
In 2017, a nationwide survey of US CIDP patients was conducted to assess the impact…
Research in CIDP: Are we making progress?
By Jeffrey A. Allen, MDMember, GBS|CIDP Foundation Global Medical Advisory Board CIDP as a named…
Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP
David Saperstein, MDCo-Director GBS/CIDP Center of ExcellencePhoenix Neurological AssociatesPhoenix, AZ Intravenous immunoglobulin (IVIg) is one…
2018 Research Grant Finalists Announced
Research is critical to serving the cause and the community. The GBS-CIDP Foundation International believes…
FDA approves CSL Behring treatment for CIDP
The Food and Drug Administration granted marketing clearance Friday for Hizentra, a treatment for chronic inflammatory demyelinating…
2017 GBS|CIDP Foundation Grant Awardees
(#1) Title of the project: Enhance Peripheral Nerve Repair by Modulating Macrophage Subsets Investigator: Gang Zhang, M.D;…